Detalles de la búsqueda
1.
Azadirachtin inhibits amyloid formation, disaggregates pre-formed fibrils and protects pancreatic ß-cells from human islet amyloid polypeptide/amylin-induced cytotoxicity.
Biochem J
; 476(5): 889-907, 2019 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30814273
2.
A review of clinical evidence to assess differences in efficacy and safety of luteinizing hormone-releasing hormone (LHRH) agonist (goserelin) and LHRH antagonist (degarelix).
Indian J Cancer
; 59(Supplement): S160-S174, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35343199
3.
Gonadotropin-releasing hormone agonists in prostate cancer: A comparative review of efficacy and safety.
Indian J Cancer
; 59(Supplement): S142-S159, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35343198
4.
Primary Vaginal Amelanotic Melanoma: A Diagnostic Conundrum.
Cureus
; 13(12): e20796, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35141058
5.
A review of clinical evidence to assess differences in efficacy and safety of luteinizing hormone杛eleasing hormone (LHRH) agonist (goserelin) and LHRH antagonist (degarelix)
Indian J Cancer
; 2022 Mar; 59(1): 160-174
Artículo
| IMSEAR | ID: sea-221746
6.
Gonadotropin?releasing hormone agonists in prostate cancer: A comparative review of efficacy and safety
Indian J Cancer
; 2022 Mar; 59(1): 142-159
Artículo
| IMSEAR | ID: sea-221745
Resultados
1 -
6
de 6
1
Próxima >
>>